57 related articles for article (PubMed ID: 7372248)
21. Hypercalciuria and hyperuricosuria in patients with calcium nephrolithiasis.
Coe FL; Kavalach AG
N Engl J Med; 1974 Dec; 291(25):1344-50. PubMed ID: 4610395
[No Abstract] [Full Text] [Related]
22. Treatment of renal calculi.
Coe FL; Favus MJ
Adv Intern Med; 1980; 26():373-92. PubMed ID: 7013442
[No Abstract] [Full Text] [Related]
23. [Medical treatment of idiopathic calcium lithiasis (II)].
Bataille P; Finet M; Renaud H; Fievet P; Rogez JC; Fournier A
Nephrologie; 1985; 6(4):195-202. PubMed ID: 2418378
[No Abstract] [Full Text] [Related]
24. [Hyperuricemia, gout and gout-induced nephropathy].
Arkhipov VE; Borisov IA; Nasonov EL; Sura VV
Ter Arkh; 1980; 52(4):133-42. PubMed ID: 6996182
[No Abstract] [Full Text] [Related]
25. Etiopathogenesis, clinical manifestations, and management of canine calcium oxalate urolithiasis.
Osborne CA; Poffenbarger EM; Klausner JS; Johnston SD; Griffith DP
Vet Clin North Am Small Anim Pract; 1986 Jan; 16(1):133-70. PubMed ID: 3518199
[TBL] [Abstract][Full Text] [Related]
26. Pathogenesis and treatment of calcium stones.
Parks JH; Coe FL
Semin Nephrol; 1996 Sep; 16(5):398-411. PubMed ID: 8890396
[TBL] [Abstract][Full Text] [Related]
27. [Gout. Clinical aspects, pathogenesis, current treatment].
Galmiche P
Cah Med; 1971 Apr; 12(6):403-13. PubMed ID: 4934051
[No Abstract] [Full Text] [Related]
28. [Metabolic factors associated with urolithiasis. Part II (author's transl)].
Kuska J
Przegl Lek; 1974; 31(12):982-6. PubMed ID: 4614334
[No Abstract] [Full Text] [Related]
29. [Benzbromarone in the treatment of gout].
Kawenoki-Minc E; Brzozowska-Jurkowska AM
Reumatologia; 1980; 18(1):61-7. PubMed ID: 6994191
[No Abstract] [Full Text] [Related]
30. Long-term management of gout and hyperuricaemia.
Scott JT
Br Med J; 1980 Nov; 281(6249):1164-6. PubMed ID: 6775757
[No Abstract] [Full Text] [Related]
31. Drugs and uric acid.
Rundles RW; Wyngaarden JB
Annu Rev Pharmacol; 1969; 9():345-62. PubMed ID: 4953095
[No Abstract] [Full Text] [Related]
32. [Various pathophysiological, clinical and therapeutic problems of disorders of purine metabolism].
Chodorowski Z
Pol Tyg Lek; 1982 Oct; 37(40):1211-3. PubMed ID: 6761669
[No Abstract] [Full Text] [Related]
33. Prevention of stone disease.
Porena M; Guiggi P; Micheli C
Urol Int; 2007; 79 Suppl 1():37-46. PubMed ID: 17726351
[TBL] [Abstract][Full Text] [Related]
34. Is there a need for medical evaluation and treatment of nephrolithiasis in the "age of lithotripsy"?
Preminger GM
Semin Urol; 1994 Feb; 12(1):51-64. PubMed ID: 8197337
[No Abstract] [Full Text] [Related]
35. [Gout. Diagnosis--pathogenesis--therapy].
Schräpler P; Schulz E; Kleinschmidt A
Fortschr Med; 1978 Mar; 96(12):665-70. PubMed ID: 344175
[No Abstract] [Full Text] [Related]
36. [Uric acid calculosis].
Kracht H; Kollwitz AA
Dtsch Med J; 1970 Apr; 21(8):515-26. PubMed ID: 4928541
[No Abstract] [Full Text] [Related]
37. [Therapy of gout].
Heidelmann G; Thiele P
Z Gesamte Inn Med; 1977 Jul; 32(14):351-5. PubMed ID: 335684
[TBL] [Abstract][Full Text] [Related]
38. [Hyperparathyroidism in urology today. New etiopathogenetic, diagnostic and therapeutic acquisitions].
Giuliani L; Carmignani G; Belgrano E; Puppo P; Cichero A; Repetto U
Minerva Urol; 1980; 32(3):133-52. PubMed ID: 6776394
[No Abstract] [Full Text] [Related]
39. Lowering serum uric acid levels: what is the optimal target for improving clinical outcomes in gout?
Perez-Ruiz F; Lioté F
Arthritis Rheum; 2007 Oct; 57(7):1324-8. PubMed ID: 17907217
[No Abstract] [Full Text] [Related]
40. Uric acid nephrolithiasis.
Halabe A; Sperling O
Miner Electrolyte Metab; 1994; 20(6):424-31. PubMed ID: 7783706
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
